The Ukrainian government at a meeting on May 10 is to approve a list of largest facilities for privatization in 2018, which will launch the process of preparation of them for privatization which could start at the end of this autumn, acting Head of the State Property Fund of Ukraine (SPF) Vitaliy Trubarov has said. “If we have the timing of all the procedures in a single thread, then we get actual privatization – this is the end of the autumn, relatively speaking, from the middle of October through December,” he said on Channel 5 TV.
Trubarov said that the SPF as soon as possible after the meeting of the Cabinet of Ministers will launch all the required procedures, including selection of advisers.
“There is a danger that the procedures that we will launch this year will not be finished before the end of the year. We will transfer some of the facilities to the beginning of 2019,” he said.
Answering the question about the term of the privatization of the Odesa Port-Side Plant, which tenders in 2017 ended twice as a failure, Trubarov called this facility “the most problematic” and urged not to hurry with a new attempt of selling it because of the unsolved debt problem. “The most important problem is its debts, which are fixed by the court decision. Unfortunately, at the moment we are just approaching the decision together with our international advisors to the issue related to the possibility of debt restructuring,” he said. “So far we have not found a solution to what to do with the debt. We do not need to put it up for sale now. We still have time, in this situation it is better not to rush,” the head of the SPF said.
Public joint-stock company Farmak, the pharmaceutical company of Ukraine of the top three largest companies in the country, is mulling the possibility of acquiring a pharmaceutical company in Europe, acting CEO Volodymyr Kostiuk has said. “Now we are looking for a company which could be bought,” he told reporters.
Kostiuk said that this is the acquisition of an industrial company or a company with a product portfolio in Europe.
“Poland was the first step. Now we are looking at Hungary and Croatia. There is a concrete targeted profile. We are trying to meet it and select companies-candidates,” he said.
Kostiuk said that Farmak does not set the terms for acquiring the company and behaves thoughtfully regarding the cost of the asset.
“We are not in a hurry. We want to find the company that meets our plans as fully as possible,” he said.
In turn, Farmak Technical Director Andriy Hoi did not rule out that production of cancer treating medicines will be organized at the facilities of Farmak.
“These are very expensive medicines. They have a high production cost. These are highly active medications. Having several cancer treating medicines in our portfolio, including from post-Soviet solutions, we are working with leading Western companies regarding the localization of production of these medicines. We are thinking on starting a separate production line in the medium term outlook and a separate line of highly active medications,” he said.
Ukraine in January-April 2018 increased exports of steel-making pig iron in natural terms by 87.7% compared to the same period last year, to 1.023 million tonnes.
According to customs statistics released by the State Fiscal Service of Ukraine, during this period exports of pig iron in monetary terms increased by 2.2 times, to $339.946 million.
At the same time, exports were mainly carried out to the United States (47.66% of deliveries in monetary terms), Italy (19.33%), and Turkey (10.94%).
Ukraine in January-April 2018 imported 414 tonnes of similar products for $256,000, whereas in January-April 2017 some 1,022 tonnes for $522,000. Imports were carried out from Russia (67.97% of deliveries in monetary terms), and Germany (32.03%).
The net loss of Bank Credit Dnepr (Kyiv) for January-March 2018 amounted to UAH 116.924 million, which is twice as much as in the same period of 2017.
According to the financial report posted on the bank’s website, its net interest income decreased by 36.9%, to UAH 40.23 million, net commission income by 30%, to UAH 29.873 million. Other non-interest loss amounted to UAH 24.105 million against UAH 30.15 million of other non-interest income in January-March 2017.
Operating expenses increased by 4%, to UAH 127.942 million.
The bank’s assets for the three months decreased by 9.36%, to UAH 8.417 billion. The loan portfolio was almost unchanged and by the end of March stood at UAH 4.116 billion.
In liabilities, the deposit portfolio decreased by 8.13%, to UAH 7.658 billion
Bank Credit Dnepr was founded in 1993. Its only owner is Victor Pinchuk.
The bank ranked 21st among 84 operating banks in the country as of January 1, 2018 in terms of total assets (UAH 9.411 billion), according to the National Bank of Ukraine.
The pig breeding company with 100% with Danish capital Goodvalley Ukraine (Ivano-Frankivsk region) plans to build a meat processing plant on the territory of Viktorivka rural council in Halych district of Ivano-Frankivsk region. According to the Halych District Administration, the memorandum of understanding was signed by the district administration, district council, town council and Goodvalley Ukraine LLC on May 4, 2018.
The discussion about the site for locating this production facility was held for the past several years.
“Several districts of Ivano-Frankivsk region competed for this investment: the choice of the location of the future production complex is linked to the fact that there are pig-breeding complexes of the company, fields for growing raw materials in Halych district, and a biogas plant is being built in the village of Tustan,” the district administration said.
As reported, Danosha from March 16, 2018 was renamed Goodvalley Ukraine.
PJSC Borschahivsky Chemical and Pharmaceutical Plant (Kyiv) in 2017 began exporting its products to Australia, Estonia and Portugal, the press service of the plant has reported. At present, the plant’s products are exported to 19 countries, including Lithuania, Latvia, and the CIS countries. At the same time, the share of exports in total sales in 2017 was 12.2%.
“In 2017 the company exported products worth UAH 152.3 million, which is 37% more than in the previous year,” the report said.
As reported, in April 2018 the Credit-Rating agency raised the long-term credit rating of the plant to the level of uaAA+ with a stable outlook.
Earlier, the plant announced its intention to expand the portfolio of veterinary drugs and biologically active additives.
PJSC Borschahivsky Chemical and Pharmaceutical Plant is one of the top 20 largest pharmaceutical manufacturers in Ukraine. It is a member of the Manufacturers of Medications of Ukraine Association.